S-C03 WBMT International Session: Global Donor Selection Challenges: Clinical Efficacy and Cost Performance

Track: BMT Tandem "Scientific" Meeting
Wednesday, February 11, 2015: 10:30 AM-12:00 PM
Harbor Ballroom ABC (Manchester Grand Hyatt)
Chairs:
Yoshihisa Kodera, MD, PhD and Daniel J. Weisdorf, MD

Disclosures:
Y. Kodera, Nothing To Disclose

D. J. Weisdorf, Alexion, Consultant, data sharing: Consultancy and Research Funding
Amgen, Consultant: Consultancy
Pharmacyclics, Consultant, study planning: Consultancy
Enlivez, Study planning: Consultancy
Therakos, Speaking/Teaching: Educational lecture
Millenium, Consultation: Consultancy

Introduction
Yoshihisa Kodera, MD, PhD, Aichi Medical University, School of Medicine

Introduction
Daniel J. Weisdorf, MD, University of Minnesota Medical Center

Medical Products of Human Origin/World Health Organization (MPHO/WHO - WBMT/TTS/ISBT/ICCBBA) Project: Regulatory Recommendations for MPHO
José Nuñez, MD, PhD, World Health Organization

Audio File Recorded Presentation
Haplo-HCT without T-Cell Depletion Vs. Unrelated Vs. Related (Post-transplant Cyclophosphamide) for Developing Countries
Dietger Niederwieser, MD, University of Leipzig

Audio File Recorded Presentation
Regional Cost Differences of Matched, Haploidentical and Cord Blood HCT
Sebastian Giebel, MD, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch

Audio File Recorded Presentation
Report from Regional Group - LABMT
Adriana Seber, MD, Instituto de Oncologia Pediatrica

See more of: BMT Tandem "Scientific" Meeting
<< Previous Session | Next Session >>